Translocator Protein Ligands
The present invention relates to compounds and methods for imaging translocator protein (18 kDa) (TSPO) expression in a subject. This invention also relates to compounds and methods for the treatment of neurodegenerative disorders, inflammation or anxiety in a subject.
Patents:WO 2,009,079,683
Inventor(s):
KASSIOU MICHAEL [AU]; JAMES MICHELLE LOUISE [US]; LUUS CHRISTOPHER ANDREW [AU]
Type of Offer:
Sale
« More Medical Patents